Please use this identifier to cite or link to this item: https://hdl.handle.net/11499/47428
Title: Circulatory 25(OH)D and 1,25(OH)2D as differential biomarkers between multiple system atrophy and Parkinson's disease patients
Authors: Ogura, Hiromu
Hatip-Al-Khatib, İzzettin
Suenaga, Midori
Bölükbaşı Hatip, Funda
Mishima, Takayasu
Fujioka, Shinsuke
Ouma, Shinji
Matsunaga, Yoichi
Tsuboi, Yoshio
Keywords: Hoehn & Yahr staging scale
Multiple system atrophy
Parkinson's disease
Unified MSA rating scale
Unified PD rating scale
Vitamin D
25 hydroxyvitamin D
calcitriol
adult
aged
area under the curve
Article
clinical assessment
controlled study
demographics
diagnostic accuracy
disease duration
female
human
major clinical study
male
middle aged
Mini Mental State Examination
Parkinson disease
predictive value
radioimmunoassay
rating scale
sensitivity and specificity
sex difference
Shy Drager syndrome
Unified Parkinson Disease Rating Scale
vitamin blood level
Publisher: Elsevier B.V.
Abstract: Background and purpose: There is sufficient evidence to support vitamin D's noncalcemic effects and the role of vitamin D deficiency in the development of a wide range of neurological disorders. This study aimed to evaluate whether serum 25(OH)D and 1,25(OH) 2 D could be used as biomarkers to differentiate between healthy subjects (HS), multiple system atrophy (MSA) and Parkinson's disease (PD) patients of both genders. Methods: A total of 107 subjects were included in this study, divided into three groups: 1- HS (n = 61), 2- MSA patients (n = 19), and 3- PD patients (n = 27). The patients were assessed using UMSARS II, UPDRS III, H&Y, MMSE and MoCA rating scales. The levels of 25(OH)D and 1,25(OH) 2 D in serum were determined using the radioimmunoassay technique. Results: The levels of 25(OH)D and 1,25(OH) 2 D in HS were 26.85 +/? 7.62 ng/mL and 53.63 +/? 13.66 pg/mL respectively. 25(OH)D levels were lower in both MSA and PD by 61% and 50%, respectively (P = 0.0001 vs. HS). 1,25(OH) 2 D levels were lower in MSA by 29%(P = 0.001 vs HS). There was a correlation between 25(OH)D and 1,25(OH) 2 D in MSA and PD, but not in HS. 1,25(OH) 2 D regressed with MMSE (? = 0.476, P = 0.04, R 2 = 0.226) in MSA, and with UPDRS III (? = ?0.432, P = 0.024, R 2 = 0.187) and MoCA (? = 0.582, P = 0.005,R 2 = 0.279) in PD. 25(OH)D displayed considerable differentiative strength between HS and MSA (Wald = 17.123, OR = 0.586, P = 0.0001; AUC = 0.982, sensitivity and Youden index = 0.882, P = 0.0001) and PD (Wald = 18.552, OR = 0.700, P = 0.0001; AUC = 0.943, sensitivity = 0.889, YI = 0.791, P = 0.0001). 1,25(OH) 2 D distinguished MSA from PD (Wald 16.178, OR = 1.117, P = 0.0001; AUC = 0.868, sensitivity = 0.926, Youden index =0.632, P = 0.0001). H&Y exhibited the highest sensitivity, AUC, and significant distinguishing power between MSA and PD. Conclusions: Serum 25(OH)D and 1,25(OH) 2 D could be useful biomarkers for MSA and PD. 25(OH)D and H&Y provided the highest sensitivity and group classification characteristics. © 2018
URI: https://doi.org/10.1016/j.ensci.2021.100369
https://hdl.handle.net/11499/47428
ISSN: 2405-6502
Appears in Collections:Scopus İndeksli Yayınlar Koleksiyonu / Scopus Indexed Publications Collection
Tıp Fakültesi Koleksiyonu

Files in This Item:
File SizeFormat 
1-s2.0-S2405650221000617-main.pdf1.06 MBAdobe PDFView/Open
Show full item record



CORE Recommender

Google ScholarTM

Check




Altmetric


Items in GCRIS Repository are protected by copyright, with all rights reserved, unless otherwise indicated.